Dysregulation and overexpression of the EGFR-signaling pathway in several cancers ameliorate carcinogenesis (Ritter and Arteaga, 2003), angiogenesis (Minder et al., 2015), cancer progression (Franklin et al., 2002; Yoon et al., 2004) and cellular survival (Yang et al., 2014). Here, EGFR is linked to cancer.